Cargando…
The Heparan Sulfate Binding Peptide in Tumor Progression of Triple-Negative Breast Cancer
Angiogenesis is the formation of new vessels from pre-existing vasculature. The heparan sulfate chains from endothelial cell proteoglycans interact with the major angiogenic factors, regulating blood vessels´ formation. Since the FDA´s first approval, anti-angiogenic therapy has shown tumor progress...
Autores principales: | Melo, Carina Mucciolo, Wang, Huawei, Fujimura, Ken, Strnadel, Jan, Meneghetti, Maria Cecília Zorél, Nader, Helena Bonciani, Klemke, Richard L., Pinhal, Maria Aparecida Silva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372403/ https://www.ncbi.nlm.nih.gov/pubmed/34422650 http://dx.doi.org/10.3389/fonc.2021.697626 |
Ejemplares similares
-
Heparan sulfate mediates trastuzumab effect in breast cancer cells
por: Suarez, Eloah Rabello, et al.
Publicado: (2013) -
Heparan Sulfate Proteoglycans in Human Colorectal Cancer
por: Vicente, Carolina Meloni, et al.
Publicado: (2018) -
Prospective evaluation of Chondroitin sulfate, Heparan sulfate and Hyaluronic acid in prostate cancer
por: da Silva, Matheus N. Ribeiro, et al.
Publicado: (2018) -
Using NMR to Dissect
the Chemical Space and O-Sulfation Effects
within the O- and S-Glycoside
Analogues of Heparan Sulfate
por: Meneghetti, Maria C.Z., et al.
Publicado: (2022) -
Heparan sulfates and heparan sulfate binding proteins in sepsis
por: Liao, Yi-En, et al.
Publicado: (2023)